Additional Imaging Prior to Cancer Surgery May Not Be Warranted
By MedImaging International staff writers Posted on 28 May 2014 |
Image: Colorectal cancer showing metastatic disease to the liver on FDG PET imaging. The heart shows the most FDG uptake (normal). Just below and to the right are two foci of increased FDG uptake showing cancer in the liver (Photo courtesy of Johns Hopkins Medicine).
Among patients with a specific type of colorectal cancer with limited metastasis to the liver, imaging using positron emission tomography (PET) and computed tomography (CT) before surgery did not significantly change the surgical treatment of the cancer, compared with just using CT scanning.
The findings were published May 13, 2014, in the Journal of the American Medical Association (JAMA). Colorectal cancer is a leading cause of cancer death. About 50% of patients present with or subsequently develop cancer that has spread to the liver. Some patients with liver metastases are candidates for surgery to have the cancer removed. However, unidentified occult metastases at the time of surgery can render the operation noncurative. Therefore, long-term survival after surgical resection (removal) for colorectal cancer liver metastases is only approximately 50%. PET-CT imaging technology could help avoid noncurative surgery by identifying patients with occult metastases, according to the researchers.
Carol-Anne Moulton, MB, BS, from the University Health Network (Toronto, Canada), and colleagues randomly ascribed patients with colorectal cancer treated by surgery with resectable metastases based on CT scans to PET-CT (n = 270) or CT only (n = 134) to determine the effect on the surgical treatment of these patients. The study, conducted between 2005 and 2013, involved 21 surgeons at nine hospitals in Ontario.
Of the 263 patients who received PET-CT scans, 111 provided new data: 62 were categorized as negative and 49 had abnormal or suspicious lesions. Change in management (canceled, more extensive liver surgery, or surgery performed on additional organs) as a result of the PET-CT findings occurred in 8.7% of patients; 2.7% avoided noncurative liver surgery. Overall, liver resection was performed on 91% of patients in the PET-CT group and 92% of the control group.
The median follow-up was three years. The researchers discovered no substantial disparity in survival or disease-free survival between patients in the PET-CT group vs. the control group. “Many countries struggle to maintain quality healthcare within existing budgets. This is difficult because of increasing healthcare costs as a result of an aging population and the expense of new therapies and technologies, including diagnostic and functional imaging,” the authors wrote in their article. “Among patients with potentially resectable hepatic metastases of colorectal adenocarcinoma, the use of PET-CT compared with CT alone did not result in frequent change in surgical management. These findings raise questions about the value of PET-CT scans in this setting.”
Related Links:
University Health Network
The findings were published May 13, 2014, in the Journal of the American Medical Association (JAMA). Colorectal cancer is a leading cause of cancer death. About 50% of patients present with or subsequently develop cancer that has spread to the liver. Some patients with liver metastases are candidates for surgery to have the cancer removed. However, unidentified occult metastases at the time of surgery can render the operation noncurative. Therefore, long-term survival after surgical resection (removal) for colorectal cancer liver metastases is only approximately 50%. PET-CT imaging technology could help avoid noncurative surgery by identifying patients with occult metastases, according to the researchers.
Carol-Anne Moulton, MB, BS, from the University Health Network (Toronto, Canada), and colleagues randomly ascribed patients with colorectal cancer treated by surgery with resectable metastases based on CT scans to PET-CT (n = 270) or CT only (n = 134) to determine the effect on the surgical treatment of these patients. The study, conducted between 2005 and 2013, involved 21 surgeons at nine hospitals in Ontario.
Of the 263 patients who received PET-CT scans, 111 provided new data: 62 were categorized as negative and 49 had abnormal or suspicious lesions. Change in management (canceled, more extensive liver surgery, or surgery performed on additional organs) as a result of the PET-CT findings occurred in 8.7% of patients; 2.7% avoided noncurative liver surgery. Overall, liver resection was performed on 91% of patients in the PET-CT group and 92% of the control group.
The median follow-up was three years. The researchers discovered no substantial disparity in survival or disease-free survival between patients in the PET-CT group vs. the control group. “Many countries struggle to maintain quality healthcare within existing budgets. This is difficult because of increasing healthcare costs as a result of an aging population and the expense of new therapies and technologies, including diagnostic and functional imaging,” the authors wrote in their article. “Among patients with potentially resectable hepatic metastases of colorectal adenocarcinoma, the use of PET-CT compared with CT alone did not result in frequent change in surgical management. These findings raise questions about the value of PET-CT scans in this setting.”
Related Links:
University Health Network
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection